Healthcare provider profile · identity verified

Peter Alan Good, MD

Internal Medicine · DULUTH, MN · NPI 1417913500

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1125	317
Lisinopril	Lisinopril	687	188
Amlodipine Besylate	Amlodipine Besylate	660	180
Levothyroxine Sodium	Levothyroxine Sodium	430	111
Metoprolol Succinate	Metoprolol Succinate	428	132
Rosuvastatin Calcium	Rosuvastatin Calcium	412	134
Omeprazole	Omeprazole	407	124
Losartan Potassium	Losartan Potassium	368	98
Gabapentin	Gabapentin	337	77
Tamsulosin Hcl	Tamsulosin Hcl	273	84
Sertraline Hcl	Sertraline Hcl	272	59
Hydrochlorothiazide	Hydrochlorothiazide	265	78
Metformin Hcl Er	Metformin Hcl	228	63
Pantoprazole Sodium	Pantoprazole Sodium	208	49
Eliquis	Apixaban	200	46
Allopurinol	Allopurinol	195	51
Metformin Hcl	Metformin Hcl	181	56
Duloxetine Hcl	Duloxetine Hcl	177	36
Famotidine	Famotidine	169	49
Furosemide	Furosemide	168	54
Warfarin Sodium	Warfarin Sodium	166	39
Trazodone Hcl	Trazodone Hcl	159	46
Metoprolol Tartrate	Metoprolol Tartrate	142	37
Potassium Chloride	Potassium Chloride	136	38
Simvastatin	Simvastatin	135	36
Jardiance	Empagliflozin	110	29
Alendronate Sodium	Alendronate Sodium	101	21
Montelukast Sodium	Montelukast Sodium	98	25
Ozempic	Semaglutide	93	19
Albuterol Sulfate Hfa	Albuterol Sulfate	92	39
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	91	27
Chlorthalidone	Chlorthalidone	88	28
Ezetimibe	Ezetimibe	86	27
Fluoxetine Hcl	Fluoxetine Hcl	84	20
Spironolactone	Spironolactone	80	26
Tramadol Hcl	Tramadol Hcl	78	16
Glipizide Er	Glipizide	75	23
Trulicity	Dulaglutide	74	14
Prednisone	Prednisone	73	42
Fluticasone Propionate	Fluticasone Propionate	71	33
Lorazepam	Lorazepam	66	21
Xarelto	Rivaroxaban	63	26
Isosorbide Mononitrate Er	Isosorbide Mononitrate	62	20
Tizanidine Hcl	Tizanidine Hcl	62	19
Valsartan	Valsartan	60	16
Finasteride	Finasteride	59	18
Pioglitazone Hcl	Pioglitazone Hcl	59	14
Carbidopa-Levodopa	Carbidopa/Levodopa	58	suppressed
Jantoven	Warfarin Sodium	56	suppressed
Irbesartan	Irbesartan	55	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	55	16
Atenolol	Atenolol	53	15
Citalopram Hbr	Citalopram Hydrobromide	53	18
Pregabalin	Pregabalin	53	15
Carvedilol	Carvedilol	52	17
Pravastatin Sodium	Pravastatin Sodium	52	16
Escitalopram Oxalate	Escitalopram Oxalate	51	15
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	51	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	48	14
Celecoxib	Celecoxib	46	13
Ventolin Hfa	Albuterol Sulfate	46	20
Zolpidem Tartrate	Zolpidem Tartrate	46	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	43	14
Doxazosin Mesylate	Doxazosin Mesylate	42	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	42	19
Donepezil Hcl	Donepezil Hcl	41	12
Lamotrigine	Lamotrigine	38	suppressed
Baclofen	Baclofen	37	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	35	11
Clonazepam	Clonazepam	35	suppressed
Bupropion Xl	Bupropion Hcl	34	12
Clopidogrel	Clopidogrel Bisulfate	34	15
Glipizide	Glipizide	34	suppressed
Oxycodone Hcl	Oxycodone Hcl	34	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	33	suppressed
Diclofenac Sodium	Diclofenac Sodium	32	11
Nitroglycerin	Nitroglycerin	32	29
Lovastatin	Lovastatin	31	suppressed
Nystatin	Nystatin	31	20
Triamcinolone Acetonide	Triamcinolone Acetonide	31	25
Quetiapine Fumarate	Quetiapine Fumarate	30	11
Levetiracetam	Levetiracetam	29	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	29	suppressed
Topiramate	Topiramate	29	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	28	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	27	16
Valacyclovir	Valacyclovir Hcl	27	12
Glimepiride	Glimepiride	26	suppressed
Lithium Carbonate	Lithium Carbonate	26	suppressed
Mirtazapine	Mirtazapine	26	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	26	suppressed
Terazosin Hcl	Terazosin Hcl	26	suppressed
Propranolol Hcl	Propranolol Hcl	25	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Ibuprofen	Ibuprofen	23	suppressed
Latanoprost	Latanoprost	23	suppressed
Meloxicam	Meloxicam	23	suppressed
Synthroid	Levothyroxine Sodium	23	suppressed
Buspirone Hcl	Buspirone Hcl	22	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	21	suppressed
Azithromycin	Azithromycin	21	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	21	suppressed
Estradiol	Estradiol	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Lansoprazole	Lansoprazole	19	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Mounjaro	Tirzepatide	19	suppressed
Novofine 32	Pen Needle, Diabetic	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	19	suppressed
Diazepam	Diazepam	18	suppressed
Divalproex Sodium	Divalproex Sodium	18	suppressed
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	18	suppressed
Digoxin	Digoxin	17	suppressed
Incruse Ellipta	Umeclidinium Bromide	17	suppressed
Metronidazole	Metronidazole	17	suppressed
Naproxen	Naproxen	17	suppressed
Klor-Con M20	Potassium Chloride	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	suppressed
Primidone	Primidone	16	suppressed
Propranolol Hcl Er	Propranolol Hcl	16	suppressed
Risperidone	Risperidone	16	suppressed
Amoxicillin	Amoxicillin	15	11
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	15	suppressed
Fluconazole	Fluconazole	15	13
Novolog Flexpen	Insulin Aspart	15	suppressed
Labetalol Hcl	Labetalol Hcl	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Ramipril	Ramipril	14	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Amantadine	Amantadine Hcl	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Repatha Sureclick	Evolocumab	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Epinephrine	Epinephrine	11	suppressed
Eszopiclone	Eszopiclone	11	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed
Insulin Aspart Flexpen	Insulin Aspart	11	suppressed
Loperamide	Loperamide Hcl	11	suppressed
Testosterone	Testosterone	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed
Wegovy	Semaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error